KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VivoSim Labs (VIVS) Common Equity (2016 - 2025)

VivoSim Labs (VIVS) has 16 years of Common Equity data on record, last reported at $4.4 million in Q4 2025.

  • For Q4 2025, Common Equity rose 1120.05% year-over-year to $4.4 million; the TTM value through Dec 2025 reached $4.4 million, up 1120.05%, while the annual FY2025 figure was $10.5 million, 191.36% up from the prior year.
  • Common Equity reached $4.4 million in Q4 2025 per VIVS's latest filing, down from $7.1 million in the prior quarter.
  • Across five years, Common Equity topped out at $39.2 million in Q1 2021 and bottomed at $364000.0 in Q4 2024.
  • Average Common Equity over 5 years is $16.7 million, with a median of $11.1 million recorded in 2023.
  • Peak YoY movement for Common Equity: tumbled 94.11% in 2024, then soared 1120.05% in 2025.
  • A 5-year view of Common Equity shows it stood at $31.3 million in 2021, then decreased by 28.77% to $22.3 million in 2022, then tumbled by 72.26% to $6.2 million in 2023, then crashed by 94.11% to $364000.0 in 2024, then skyrocketed by 1120.05% to $4.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $4.4 million in Q4 2025, $7.1 million in Q3 2025, and $9.5 million in Q2 2025.